Intended Use: For laboratory research use only Key Characteristics of BPC-157 (15 mg) Supplied as a high-purity, lyophilized research peptide Defined amino acid sequence supports consistent and reproducible experimental outcomes Commonly used in cell-based and tissue-focused research models where structural integrity, barrier properties, or injury-related responses are measured Higher total peptide content supports extended or multi-phase experimental workflows Stable under recommended storage conditions Compatible with standard laboratory peptide handling and reconstitution protocols How BPC-157 (15 mg) Supports Research In research settings, BPC-157 is used to study peptide-driven cellular communication and signaling
Special Considerations for Different Types of Thalassemia Thalassemia comes in different types, each with its own challenges
Contact your provider and/or the pharmacy
Our board-certified physicians take the time to evaluate your unique needs before recommending any NAD protocol
Frequently Asked Questions About IGF-1 LR3 1mg IGF-1 LR3 differs from native IGF-1 (70 amino acids) through two modifications: a 13-amino acid N-terminal extension peptide and the substitution of glutamic acid at position 3 with arginine (Glu3 to Arg3, hence 'R3' in the name), resulting in an 83-amino acid protein with a molecular weight of 9,111 Da compared to native IGF-1's 7,649 Da
BPC-157 alone is a local-acting peptide most clinically useful in acute soft-tissue and gut indications
